- Home
- USNA vs EYPT Comparison
USNA vs EYPT Comparison
Compare USNA & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USNA
- EYPT
- Stock Information
- Founded
- USNA 1992
- EYPT 1987
- Country
- USNA United States
- EYPT United States
- Employees
- USNA N/A
- EYPT N/A
- Industry
- USNA Medicinal Chemicals and Botanical Products
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- USNA Health Care
- EYPT Industrials
- Exchange
- USNA Nasdaq
- EYPT Nasdaq
- Market Cap
- USNA 565.2M
- EYPT 579.4M
- IPO Year
- USNA 1996
- EYPT 2005
- Fundamental
- Price
- USNA $32.01
- EYPT $9.55
- Analyst Decision
- USNA Hold
- EYPT Strong Buy
- Analyst Count
- USNA 1
- EYPT 8
- Target Price
- USNA $36.00
- EYPT $24.75
- AVG Volume (30 Days)
- USNA 156.2K
- EYPT 841.7K
- Earning Date
- USNA 07-22-2025
- EYPT 08-06-2025
- Dividend Yield
- USNA N/A
- EYPT N/A
- EPS Growth
- USNA N/A
- EYPT N/A
- EPS
- USNA 1.82
- EYPT N/A
- Revenue
- USNA $876,242,000.00
- EYPT $56,042,000.00
- Revenue This Year
- USNA $13.04
- EYPT N/A
- Revenue Next Year
- USNA $7.36
- EYPT N/A
- P/E Ratio
- USNA $17.62
- EYPT N/A
- Revenue Growth
- USNA N/A
- EYPT 12.04
- 52 Week Low
- USNA $23.10
- EYPT $3.91
- 52 Week High
- USNA $48.85
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- USNA 54.23
- EYPT 61.03
- Support Level
- USNA $30.36
- EYPT $7.94
- Resistance Level
- USNA $31.43
- EYPT $10.77
- Average True Range (ATR)
- USNA 0.71
- EYPT 0.76
- MACD
- USNA -0.03
- EYPT -0.01
- Stochastic Oscillator
- USNA 57.94
- EYPT 56.89
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.